Veterinary longevity medicine
Longitudinal health management for dogs. Evidence-guided pharmacology, gene therapy, and regenerative medicine.
What we do
Longitudinal assessment
Clinical evaluation, imaging, molecular profiling. AI-assisted biomarker analysis with individualised reference ranges.
Pharmacological intervention
Rapamycin, procyanidin C1, SGLT2 inhibitors, acarbose. Dose titration based on continuous monitoring.
Gene therapy
AAV-mediated delivery of follistatin, Klotho, TERT. Clinical-grade vectors, sterile administration.
Cell therapy
Autologous and allogeneic NK cells. Adipose-derived mesenchymal stem cells. GMP protocols.
Oncology
Molecular characterisation of tumours. Multi-modal therapy design. Integration with standard oncology.
Diagnostics
Genomic sequencing, metabolomics, proteomics. Serial biomarker tracking. Interpretation in clinical context.
What this is
A veterinary longevity clinic in London. We work with dogs, primarily. Clinical assessment, molecular diagnostics, evidence-based intervention. Most work is longitudinal—serial measurements, protocol refinement, outcome tracking.